Orexigen Therapeutics, Inc.
(Other OTC/NBB : OREX)

( )
OREX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.17%203.561.3%$427.08m
BIIBBiogen Inc.
-0.93%225.601.3%$388.53m
GILDGilead Sciences, Inc.
-0.35%65.000.9%$366.13m
CELGCelgene Corporation
0.82%101.801.3%$356.32m
ILMNIllumina, Inc.
0.28%310.553.5%$253.40m
REGNRegeneron Pharmaceuticals, Inc.
0.73%301.572.6%$219.86m
EXASExact Sciences Corporation
-0.20%97.3924.1%$203.99m
ALXNAlexion Pharmaceuticals, Inc.
0.48%99.992.0%$181.39m
VRTXVertex Pharmaceuticals Incorporated
0.93%177.721.9%$178.93m
AAgilent Technologies, Inc.
-0.47%74.921.6%$143.96m
SRPTSarepta Therapeutics, Inc.
0.81%87.4414.6%$138.15m
BMRNBioMarin Pharmaceutical Inc.
-0.06%67.904.3%$95.86m
SGENSeattle Genetics, Inc.
2.48%85.946.2%$90.55m
NKTRNektar Therapeutics
1.31%17.775.5%$84.92m
ALDRAlder Biopharmaceuticals, Inc.
0.16%18.9010.2%$83.36m

Company Profile

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.